Table 4.
QALYs and (specified) costs per patient during the first year of follow-up
| QALYs and costs | iMTX (n = 44) | iHCQ (n = 35) | iGCs (n = 37) |
|---|---|---|---|
| QALYs (EQ-5D-3L, AUC) | 0.71 (0.14) | 0.73 (0.14) | 0.71 (0.15) |
| Total costs, € | 10 832 (14 763) | 11 208 (12 801) | 10 502 (11 973) |
| Total healthcare costs, € | 2584 (2196) | 2123 (2172) | 3050 (3461) |
| Medication, € | 1471 (2136) | 821 (1510) | 1960 (2933) |
| Medical consumption, € | 972 (717) | 1133 (1392) | 1090 (1080) |
| Hospitalization, € | 141 (634) | 169 (602) | − |
| Total productivity costs, € | 8249 (14 171) | 9085 (11 571) | 7453 (10 446) |
| Absenteeism, € | 6750 (12 804) | 6070 (7984) | 6469 (9506) |
| Presenteeism, € | 1499 (2921) | 3015 (5157) | 984 (1693) |
Results shown are mean (s.d.).
AUC: area under the curve; EQ-5D-3L: European Quality of Life 5-Dimensions 3 Levels; iGCs: initial glucocorticoids; iHCQ: initial HCQ; iMTX: initial MTX; QALYs: quality-adjusted life years.